Issues surrounding lymphadenectomy in the management of endometrial cancer

Journal of Surgical Oncology

Volumn 99, Issue 4, 2009, Pages 232-241

  Bernardini, Marcus Q ^a,b   Murphy, Joan K ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Endometrial cancer; Lymphadenectomy; Surgical staging

Indexed keywords

ADJUVANT THERAPY; CANCER STAGING; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; ENDOMETRIUM CANCER; HUMAN; LYMPHADENECTOMY; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE;

CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY;

EID: 62749189918     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21200     Document Type: Review

References (62)

1. Creasman WT, Morrow CP, Bundy BN, et al.: Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-2041.
2. Morrow CP, Bundy BN, Kurman RJ, et al.: Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
3. Creutzberg CL, van Putten WL, Koper PC, et al.: Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-1411.
4. Trimble EL, Kosary C, Park RC: Lymph node sampling and survival in endometrial cancer. Gynecol Oncol 1998;71:340-343.
5. Keys HM, Roberts JA, Brunetto VL, et al.: A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group Study. Gynecol Oncol 2004;92:744-751.
6. Sanjuan A, Cobo T, Pahisa J, et al.: Preoperative and intraoperative assessment of myometrial invasion and histologic grade in endometrial cancer: Role of magnetic resonance imaging and frozen section. Int J Gynecol Cancer 2006;16:385-390.
7. Connor JP, Andrews JI, Anderson B, et al.: Computed tomography in endometrial carcinoma. Obstet Gynecol 2000;95:692-696.
8. Hardesty LA, Sumkin JH, Hakim C, et al.: The ability of helical CT to preoperatively stage endometrial carcinoma. Am J Roentgenol 2001;176:603-606.
9. Nakao Y, Yokoyama M, Hara K, et al.: MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion. Gynecol Oncol 2006;102:343-347.
10. Akin O, Mironov S, Pandit-Taskar N, et al.: Imaging of uterine cancer. Radiol Clin North Am 2007;45:167-182.
11. Manfredi R, Mirk P, Maresca G, et al.: Local-regional staging of endometrial carcinoma: Role of MR imaging in surgical planning. Radiology 2004;231:372-378.
12. Horowitz NS, Dehdashti F, Herzog TJ, et al.: Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol 2004;95:546-551.
13. Suzuki R, Miyagi E, Takahashi N, et al.: Validity of positron emission tomography using fluoro-2-deoxyglucose for the preoperative evaluation of endometrial cancer. Int J Gynecol Cancer 2007;17:890-896.
14. Cragun JM, Havrilesky LJ, Calingaert B, et al.: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005;23:3668-3675.
15. Mohan DS, Samuels MA, Selim MA, et al.: Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998;70:165-171.
16. Orr JW, Jr., Holloway RW, Orr PF, et al.: Surgical staging of uterine cancer: An analysis of perioperative morbidity. Gynecol Oncol 1991;42:209-216.
17. Hidaka T, Kato K, Yonezawa R, et al.: Omission of lymphadenectomy is possible for low-risk corpus cancer. Eur J Surg Oncol 2007;33:86-90.
18. Larson DM, Johnson K, Olson KA: Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: Morbidity and mortality. Obstet Gynecol 1992;79:998-1001.
19. Fanning J, Nanavati PJ, Hilgers RD: Surgical staging and high dose rate brachytherapy for endometrial cancer: Limiting external radiotherapy to node-positive tumors. Obstet Gynecol 1996;87:1041-1044.
20. Abu-Rustum NR, Alektiar K, Iasonos A, et al.: The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: A 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006;103:714-718.
21. Homesley HD, Kadar N, Barrett RJ, et al.: Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol 1992;167:1225-1230.
22. Walker JL, Piedmonte M, Spirtos N, et al.: Surgical staging of uterine cancer: Randomized phase III trial of laparoscopy vs laparotomy - A Gynecologic Oncology Group Study (GOG): Preliminary results. Proc Am Soc Clin Oncol 2006: 24(abstr 5010).
23. Hauspy J, Beiner M, Harley I, et al.: Sentinel lymph nodes in early stage cervical cancer. Gynecol Oncol 2007;105:285-290.
24. Burke TW, Levenback C, Tornos C, et al.: Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: Results of a pilot study. Gynecol Oncol 1996;62:169-173.
25. Holub Z, Kliment L, Lukac J, et al.: Laparoscopically-assisted intraoperative lymphatic mapping in endometrial cancer: Preliminary results. Eur J Gynaecol Oncol 2001;22:118-121.
26. Holub Z, Jabor A, Kliment L: Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: A pilot study. Eur J Gynaecol Oncol 2002;23:53-57.
27. Pelosi E, Arena V, Baudino B, et al.: Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 2002;88:S9-S10.
28. Delaloye JF, Pampallona S, Chardonnens E, et al.: Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol Oncol 2007;106:89-93.
29. Gien LT, Kwon JS, Carey MS: Sentinel node mapping with isosulfan blue dye in endometrial cancer. J Obstet Gynaecol Cancer 2005;27:1107-1112.
30. Frumovitz M, Bodurka DC, Broaddus RR, et al.: Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol Oncol 2007;104:100-103.
31. Frumovitz M, Singh DK, Meyer L, et al.: Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004;95:463-468.
32. Khalifa MA, Dodge J, Covens A, et al.: Slide review in gynecologic oncology ensures completeness of reporting and diagnostic accuracy. Gynecol Oncol 2003;90:425-430.
33. Lax SF, Kurman RJ, Pizer ES, et al.: A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000;24:1201-1208.
34. Taylor RR, Zeller J, Lieberman RW, et al.: An analysis of two versus three grades for endometrial carcinoma. Gynecol Oncol 1999;74:3-6.
35. Alkushi A, Abdul-Rahman ZH, Lim P, et al.: Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol 2005;29:295-304.
36. Bristow RE, Zerbe MJ, Rosenshein NB, et al.: Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival. Gynecol Oncol 2000;78:85-91.
37. Chi DS, Welshinger M, Venkatraman ES, et al.: The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol 1997;67:56-60.
38. Lambrou NC, Gomez-Marin O, Mirhashemi R, et al.: Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: A study of morbidity and survival. Gynecol Oncol 2004;93:653-658.
39. Chi DS, Liao JB, Leon LF, et al.: Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol 2001;82:532-537.
40. Hacker NF, Wain GV, Nicklin JL: Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995;5:250-256.
41. Hoskins WJ, McGuire WP, Brady MF, et al.: The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 1994;170:974-979; discussion 979-980.
42. Spirtos NM, Gross GM, Freddo JL, et al.: Cytoreductive surgery in advanced epithelial cancer of the ovary: The impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 1995;56:345-352.
43. Corn BW, Lanciano RM, Greven KM, et al.: Endometrial cancer with para-aortic adenopathy: Patterns of failure and opportunities for cure. Int J Radiat Oncol Biol Phys 1992;24:223-227.
44. Rose PG, Cha SD, Tak WK, et al.: Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma. Int J Radiat Oncol Biol Phys 1992;24:229-233.
45. Bristow RE, Zahurak ML, Alexander CJ, et al.: FIGO stage IIIC endometrial carcinoma: Resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 2003;13:664-672.
46. Havrilesky LJ, Cragun JM, Calingaert B, et al.: Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol Oncol 2005;99:689-695.
47. Chan JK, Cheung MK, Huh WK, et al.: Therapeutic role of lymph node resection in endometrioid corpus cancer: A study of 12,333 patients. Cancer 2006;107:1823-1830.
48. Aalders J, Abeler V, Kolstad P, et al.: Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-427.
49. Randall ME, Filiaci VL, Muss H, et al.: Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study. J Clin Oncol 2006;24:36-44.
50. Aalders JG, Thomas G: Endometrial cancer - Revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 2007;104:222-231.
51. Carey MS, O'Connell GJ, Johanson CR, et al.: Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995;57:138-144.
52. Elliott P, Green D, Coates A, et al.: The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 1994;4:84-93.
53. Larson DM, Broste SK, Krawisz BR: Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998;91:355-359.
54. Podczaski E, Kaminski P, Gurski K, et al.: Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol 1992;47:323-327.
55. Lo KW, Cheung TH, Yu MY, et al.: The value of pelvic and paraaortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy. Int J Gynecol Cancer 2003;13:863-869.
56. Chan JK, Urban R, Cheung MK, et al.: Lymphadenectomy in endometrioid uterine cancer staging: How many lymph nodes are enough? A study of 11,443 patients. Cancer 2007;109:2454-2460.
57. Chan JK, Wu H, Cheung MK, et al.: The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007;106:282-288.
58. Mariani A, Keeney GL, Aletti G, et al.: Endometrial carcinoma: Paraaortic dissemination. Gynecol Oncol 2004;92:833-838.
59. Susumu N, Sagae S, Udagawa Y, et al.: Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108:226-233.
60. Nelson G, Randall M, Sutton G, et al.: FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: Analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy. Gynecol Oncol 1999;75:211-214.
61. Kitchener H, Redman CW, Swart AM, et al.: ASTEC, A study in the treatment of endometrial cancer. A randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol 2006;101:S21-S22.
62. Maggi R, Lissoni A, Spina F, et al.: Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: Results of a randomised trial. Br J Cancer 2006;95:266-271.